PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · News & media

Mounjaro Zepbound Weight Loss: Shockingly Fast Weight Loss After Months Long Stall!

News & media17:38Sep 2024

Today’s cheapest tirzepatide$69/mo at Wellmedr, sale price.Compare all tirzepatide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

In this personal update, the host of On The Pen says he is a type 2 diabetic who has struggled to respond to GLP-1 medications the way many others do. He explains that he skipped the 7.5 milligram and 12.5 milligram Mounjaro doses early on, reached 15 milligrams within a few months, and went from about 312 lb to 276 lb. He says severe migraines then forced him to restart at 5 milligrams, and he regained weight up to about 300 lb in 2023. A stretch on Ozempic held his weight but, in his words, was not powerful enough, so he returned to Mounjaro. He says he has been on 15 milligrams for most of 2024 and had been stuck at 290 lb for two months.

Published by On The Pen™ GLP-1 News on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

He describes several changes he made recently. He changed jobs, so he no longer spends the day driving and now works from home with more intentional walking breaks. He cut back on carbohydrates to aim for ketosis, which he says suits his diabetes and energy levels, while stressing this is not diet or medical advice. He also started a daily Ro testosterone support supplement and a breath ketone meter, which he says shows his ketosis level each morning so he can spot foods that hurt it. He notes that he is a community advisor with Ro and that the meter link in the description is an Amazon affiliate link.

He reports losing 3 lb per week for two weeks, from 290 lb to 284 lb, the fastest drop in years. He closes by encouraging viewers who respond slowly to keep going, mentions CagriSema and retatrutide as upcoming medications, and previews a Senate hearing on GLP-1 prices.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 1:09 He says he skipped the 7.5 and 12.5 milligram Mounjaro doses, reached 15 milligrams quickly, and dropped from about 312 lb to 276 lb.
  2. 2:12 He says migraines forced him back to 5 milligrams, he regained weight to about 300 lb, and a switch to Ozempic only held his weight.
  3. 4:13 He says a new job with less driving and more intentional movement did not by itself move the scale from 290 lb.
  4. 5:16 He describes cutting carbohydrates to reach ketosis and reports losing 6 lb in two weeks, down to 284 lb.
  5. 8:47 He explains a breath acetone meter that shows his ketosis level each morning, which he says helps him identify foods to remove.
  6. 14:58 He encourages viewers who respond slowly to keep going, citing CagriSema and retatrutide as medications he expects in the coming years.

Key moments

Tap one to play from there.

  1. 0:00 Personal update on weight loss
  2. 1:08 Medication history and issues
  3. 4:07 Lifestyle changes and challenges
  4. 5:57 Adopting a ketogenic diet
  5. 7:04 New supplements and programs
  6. 8:25 Keto breathalyzer monitoring
  7. 12:36 Future outlook and community

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound, Mounjaro and semaglutide

Questions this video answers

How much weight did he lose after a long stall on Mounjaro 15 mg?

He says he lost 6 lb in two weeks, going from 290 lb to 284 lb, after being stuck at 290 lb for about two months. He describes it as the fastest he has lost in years.

What did he change to break a weight loss stall on Mounjaro?

He says he changed jobs to get more movement, cut carbohydrates to aim for ketosis, started a daily Ro testosterone support supplement, and began checking ketones with a breath meter. He says he cannot be sure which change mattered most.

How does a breath ketone meter work according to the video?

He says the device measures acetone in the breath, which he describes as a byproduct of burning fat, and shows a ketosis level in an app. He says it works best first thing in the morning in a fasted state and that his reading was 6.3.

Why did he stop Mounjaro doses and switch to Ozempic?

He says severe migraines in early 2023 made him lower his dose, and he later tried Ozempic for a while. He says it held his weight and helped his blood sugars but was not as powerful as he needed, so he went back to Mounjaro.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

  • Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses

    On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.

Next steps

Zepbound prices

Insurance

Find more like it

Dose changeWeigh-in and resultsCost and insurance

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV